logo
Huron's (NASDAQ:HURN) Q1: Beats On Revenue

Huron's (NASDAQ:HURN) Q1: Beats On Revenue

Yahoo30-04-2025

Professional services firm Huron Consulting Group (NASDAQ:HURN) reported Q1 CY2025 results exceeding the market's revenue expectations , with sales up 11.2% year on year to $404.1 million. The company expects the full year's revenue to be around $1.62 billion, close to analysts' estimates. Its non-GAAP profit of $1.68 per share was 45.3% above analysts' consensus estimates.
Is now the time to buy Huron? Find out in our full research report.
Revenue: $404.1 million vs analyst estimates of $401 million (11.2% year-on-year growth, 0.8% beat)
Adjusted EPS: $1.68 vs analyst estimates of $1.16 (45.3% beat)
Adjusted EBITDA: $41.49 million vs analyst estimates of $41.47 million (10.3% margin, in line)
The company reconfirmed its revenue guidance for the full year of $1.62 billion at the midpoint
Management reiterated its full-year Adjusted EPS guidance of $7.20 at the midpoint
Operating Margin: 8.1%, up from 5.5% in the same quarter last year
Free Cash Flow was -$108.7 million compared to -$139.5 million in the same quarter last year
Market Capitalization: $2.25 billion
'Driven by strong growth across all three operating segments, revenues before reimbursable expenses (RBR) grew 11% over the first quarter of 2024, while we continued to expand our margins,' said Mark Hussey, CEO and president of Huron.
Founded in 2002 during a time of significant regulatory change in corporate America, Huron Consulting Group (NASDAQ:HURN) is a professional services company that helps organizations develop growth strategies, optimize operations, and implement digital transformation solutions.
A company's long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.
With $1.56 billion in revenue over the past 12 months, Huron is a small player in the business services space, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and numerous distribution channels. On the bright side, it can grow faster because it has more room to expand.
As you can see below, Huron grew its sales at an impressive 9.7% compounded annual growth rate over the last five years. This is an encouraging starting point for our analysis because it shows Huron's demand was higher than many business services companies.
Long-term growth is the most important, but within business services, a half-decade historical view may miss new innovations or demand cycles. Huron's annualized revenue growth of 13.1% over the last two years is above its five-year trend, suggesting its demand was strong and recently accelerated.
This quarter, Huron reported year-on-year revenue growth of 11.2%, and its $404.1 million of revenue exceeded Wall Street's estimates by 0.8%.
Looking ahead, sell-side analysts expect revenue to grow 8.6% over the next 12 months, a deceleration versus the last two years. Despite the slowdown, this projection is healthy and implies the market sees success for its products and services.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Huron was profitable over the last five years but held back by its large cost base. Its average operating margin of 8.2% was weak for a business services business.
On the plus side, Huron's operating margin rose by 8.6 percentage points over the last five years, as its sales growth gave it immense operating leverage.
This quarter, Huron generated an operating profit margin of 8.1%, up 2.6 percentage points year on year. This increase was a welcome development and shows it was more efficient.
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable.
Huron's EPS grew at an astounding 19.5% compounded annual growth rate over the last five years, higher than its 9.7% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.
Diving into Huron's quality of earnings can give us a better understanding of its performance. As we mentioned earlier, Huron's operating margin expanded by 8.6 percentage points over the last five years. On top of that, its share count shrank by 15.4%. These are positive signs for shareholders because improving profitability and share buybacks turbocharge EPS growth relative to revenue growth.
In Q1, Huron reported EPS at $1.68, up from $1.23 in the same quarter last year. This print easily cleared analysts' estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Huron's full-year EPS of $6.94 to grow 6.1%.
We were impressed by how significantly Huron blew past analysts' EPS expectations this quarter. We were also happy its revenue narrowly outperformed Wall Street's estimates. Overall, we think this was a decent quarter with some key metrics above expectations. The stock traded up 1.9% to $138.60 immediately after reporting.
Huron put up rock-solid earnings, but one quarter doesn't necessarily make the stock a buy. Let's see if this is a good investment. If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs

Yahoo

timean hour ago

  • Yahoo

HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs

Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now. HC Wainwright & Co., a leading investment bank, has initiated a 'Buy' rating for Travere Therapeutics, Inc. (NASDAQ:TVTX), with a price target of $30, signaling an upside of around 100%. This confidence in the company underscores its position in the pharmaceutical sector. The company has just announced plans to present three new abstracts underscoring the impact of FILSPARI (sparsentan) in rare kidney disease at the International Podocyte Conference, taking place in Hamburg, Germany. The findings of FILSPARI, showcasing advanced reductions in urinary BAFF and sC5b9, along with dips in the proinflammatory and profibrotic biomarkers, signal a step forward in the treatment of IgAN. A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule. With net sales of FILSPARI increasing 182% year-over-year and the successful approval of FILSPARI in Europe and the UK, analysts have little doubt about the company's potential. Since the major revenue contribution comes from FILSPARI, the rising popularity and increasing adoption among nephrologists mean that Travere Therapeutics, Inc. (NASDAQ:TVTX) can continue to leverage a product that is quite differentiated. Travere Therapeutics, Inc. (NASDAQ:TVTX) is a biopharmaceutical company incorporated in 2008. This California-based giant recognizes, develops, and commercializes therapies for people suffering from rare kidney and metabolic diseases in the United States. While we acknowledge the potential of TVTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Ethereum Treasury Firm SharpLink Gaming Plunges 70% – But There May Be a Twist
Ethereum Treasury Firm SharpLink Gaming Plunges 70% – But There May Be a Twist

Yahoo

time2 hours ago

  • Yahoo

Ethereum Treasury Firm SharpLink Gaming Plunges 70% – But There May Be a Twist

SharpLink Gaming (SBET), a Nasdaq-listed company that is pursuing an ether ETH treasury strategy, tumbled 70% on Thursday in after-hours trading following a fresh filing to the U.S. Securities and Exchange Commission. The company submitted an S-3ASR registration statement, enabling the resale of up to 58,699,760 shares related to its private investment in public equity (PIPE) financing. The Thursday filing allows more than 100 shareholders in the PIPE round to sell their shares, effectively flooding the market and triggering a post-close sell-off, Charles Allen, CEO of BTCS, a publicly-traded firm that's pursuing crypto reserve strategy, explained in an X post and an interview with CoinDesk. The company raised $450 million earlier this month through a PIPE round from a wide range of investors, including ConsenSys, Galaxy, and Pantera Capital, to acquire ETH for its treasury. Ethereum co-founder and ConsenSys CEO Joseph Lubin also joined the firm as board chairman. However, there may be a larger strategy behind the latest move. Allen said in an X post that he thinks the company may have quietly raised up to $1 billion to buy more ETH using an at-the-market (ATM) offering that was previously announced in a May 30 SEC filing. "If they played cards right, they would expect a surprise PR tomorrow with $1B of ETH purchases, which could light the match to reignite the stock," he said. ETH is down 4.1% over the past 24 hours at around $2,650 as bitcoin and the broader crypto markets in retrieving data Sign in to access your portfolio Error in retrieving data

The Chime IPO Will Kickstart A Fintech Investment Comeback
The Chime IPO Will Kickstart A Fintech Investment Comeback

Forbes

time2 hours ago

  • Forbes

The Chime IPO Will Kickstart A Fintech Investment Comeback

Chris Britt, co-founder and chief executive officer of Chime Financial Inc., during the company's ... More initial public offering at the Nasdaq MarketSite in New York, US, on Thursday, June 12, 2025. Chime launched its IPO with a splash. Shares jumped as much as 59% above the $27 offering price—opening at $43 and closing near $37—marking a bold public debut for the US's largest neobank. With a valuation hovering between $11.6 billion and $15 billion—well below its 2021 private peak of $25 billion—the surge raises the question: Will this trigger renewed investment in neobanks and fintech? Chime's IPO follows strong debuts from fintechs like Circle and eToro. PitchBook's Rudy Yang framed Chime as 'a strategic breakthrough—marking a return of fintech liquidity' after the sector saw VC exit values plummet from $222 billion in 2021 to under $30 billion in the past few years. Chime could be a bellwether for a neobank--and broader fintech--recovery if it: There is another side of the coin: Is Chime's IPO really a pivotal moment for the fintech industry and a validation of the digital-banking model and a template for future bank challengers? No. Chime's debut feels more like a secure base camp than a flag planted atop Everest. It suggests that public markets are open to credible fintech challengers—provided they bring scale, strong unit economics, and realistic valuations. The critical questions for neobanks: 1) Can they diversify revenue beyond interchange (loans, wealth, insurance)? 2) Will macro conditions hold stable enough to sustain IPO markets? 3) Will consumer-trust and customer growth trajectories support future public offerings? The answers are no. There are market factors impacting neobanks that have closed the door to new neobanks coming into the market: 1) Megafintechs have better economics and business models. Among consumers who consider a digital bank or neobank their primary checking account or payments provider, half of them say their primary provider is PayPal or Square Cash App. Neobanks don't just compete with incumbent banks—they compete with the megafintechs, whose platform business models give them scale and revenue diversity. 2) Interchange isn't a reliable revenue source. Relying on interchange runs against consumer behavior trends regarding: 3) The niche affinity play is tough for startups. This strategy requires neobanks to identify a segment's unique financial needs and Be the dominant affinity. Neobanks' claims of how big their affinity groups are misleading because most of us belong to multiple affinity groups. Fintech has entered a new phase—one defined by realism, consumer impact, and long-term value creation. The new phase, however, isn't about bank disruption and displacement--it's about banking industry infrastructure upgrade and replacement. The Chime IPO will help create more VC interest in fintech investment--but that investment won't go to new neobanks. Instead, it will go to startups that bring two things to the financial services industry: 1) AI-driven process reinvention from machine learning, Generative AI, and Agentic AI tools and technologies, and 2) Stablecoin and other cryptocurrency-related payments innovation. The latter may do more to disrupt banks than Chime and other neobanks have done.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store